clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Carcinoma, Lewis Lung D018827 22 associated lipids
Fibrosis D005355 23 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Stomach Neoplasms D013274 24 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Nasal Polyps D009298 26 associated lipids
Gastritis D005756 27 associated lipids
Gastrointestinal Hemorrhage D006471 27 associated lipids
Angina Pectoris D000787 27 associated lipids
Endometriosis D004715 29 associated lipids
Proteinuria D011507 30 associated lipids
Drug Eruptions D003875 30 associated lipids
Diarrhea D003967 32 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Fever D005334 35 associated lipids
Heart Failure D006333 36 associated lipids
Lung Diseases D008171 37 associated lipids
Arthritis D001168 41 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Psoriasis D011565 47 associated lipids
Parkinson Disease D010300 53 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Pain D010146 64 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Colitis D003092 69 associated lipids
Hyperlipidemias D006949 73 associated lipids
Stomach Ulcer D013276 75 associated lipids
Arteriosclerosis D001161 86 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Insulin Resistance D007333 99 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hemolysis D006461 131 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Shojaei H et al. Chronic pulmonary disease due to Mycobacterium monacense infection: the first case from Iran. 2012 Ann Lab Med pmid:22259785
Kim SY et al. Pulmonary infection caused by Mycobacterium conceptionense. 2012 Emerging Infect. Dis. pmid:22257692
Seddon G et al. Drug design for ever, from hype to hope. 2012 J. Comput. Aided Mol. Des. pmid:22252446
Choi SJ et al. The prevalence of vaginal microorganisms in pregnant women with preterm labor and preterm birth. 2012 Ann Lab Med pmid:22563554
Bowers JR et al. Dominance of multidrug resistant CC271 clones in macrolide-resistant streptococcus pneumoniae in Arizona. 2012 BMC Microbiol. pmid:22251616
Sharma H et al. Fortuitous vasculitis. 2012 Ren Fail pmid:22250755
Goswami S et al. Anti-Helicobacter pylori potential of artemisinin and its derivatives. 2012 Antimicrob. Agents Chemother. pmid:22687518
Barberán J et al. Update on the clinical utility and optimal use of cefditoren. 2012 Int J Gen Med pmid:22675264
Cuadrado-Lavín A et al. Levofloxacin versus clarithromycin in a 10 day triple therapy regimen for first-line Helicobacter pylori eradication: a single-blind randomized clinical trial. 2012 J. Antimicrob. Chemother. pmid:22687889
Nseir W et al. Randomised clinical trial: simvastatin as adjuvant therapy improves significantly the Helicobacter pylori eradication rate--a placebo-controlled study. 2012 Aliment. Pharmacol. Ther. pmid:22646167
Zaater MF et al. Determination and stability assessment of clarithromycin in human plasma using RP-LC with electrochemical detection. 2012 J Chromatogr Sci pmid:22647394
Matsueda K et al. A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. 2012 Gut pmid:22157329
Chan A et al. A case of wrist tenosynovitis caused by Mycobacterium kansasii in a renal transplant recipient. 2012 Transpl Infect Dis pmid:22822725
Koh WJ et al. Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease. 2012 Am. J. Respir. Crit. Care Med. pmid:22878282
Maurer FP et al. Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of Mycobacterium abscessus in the presence of inducible erm(41). 2012 J. Antimicrob. Chemother. pmid:22833642
Patel N and Miller CD New option for management of HIV-1 infection in treatment-naive patients: once-daily, fixed-dose combination of rilpivirine-emtricitabine-tenofovir. 2012 HIV AIDS (Auckl) pmid:22570576
Alzolibani AA and Zedan K Macrolides in chronic inflammatory skin disorders. 2012 Mediators Inflamm. pmid:22685371
Masekela R and Green RJ The role of macrolides in childhood non-cystic fibrosis-related bronchiectasis. 2012 Mediators Inflamm. pmid:22570510
Lee MR et al. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates. 2012 J. Antimicrob. Chemother. pmid:21980068
Cuadrado-Lavín A et al. Antimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in Spain. 2012 J. Antimicrob. Chemother. pmid:21965436
Zullo A et al. Role of gastritis pattern on Helicobacter pylori eradication. 2012 Intern Emerg Med pmid:22105372
Ivetic Tkalcevic V et al. Cantharidin-induced inflammation in mouse ear model for translational research of novel anti-inflammatories. 2012 Transl Res pmid:22677362
Fujioka T et al. A large-scale nationwide multicenter prospective observational study of triple therapy using rabeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in Japan. 2012 J. Gastroenterol. pmid:22065160
Park HG et al. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients. 2012 Aliment. Pharmacol. Ther. pmid:22066530
Cetin M et al. Clarithromycin-Induced Long QT Syndrome: A Case Report. 2012 Case Rep Med pmid:22489247
Saracino IM et al. High prevalence of primary antibiotic resistance in Helicobacter pylori isolates in Italy. 2012 J Gastrointestin Liver Dis pmid:23256118
Ikegame S et al. Congenital cystic adenomatoid malformation in adulthood complicated by Mycobacterium celatum infection. 2012 Intern. Med. pmid:22892504
Tsay FW et al. Sequential therapy achieves a higher eradication rate than standard triple therapy in Taiwan. 2012 J. Gastroenterol. Hepatol. pmid:21871025
Spyridaki A et al. Effect of clarithromycin in inflammatory markers of patients with ventilator-associated pneumonia and sepsis caused by Gram-negative bacteria: results from a randomized clinical study. 2012 Antimicrob. Agents Chemother. pmid:22564837
Ngan LT et al. Growth-inhibiting, bactericidal, and urease inhibitory effects of Paeonia lactiflora root constituents and related compounds on antibiotic-susceptible and -resistant strains of Helicobacter pylori. 2012 J. Agric. Food Chem. pmid:22891951
McCallum GB et al. Antibiotics for persistent cough or wheeze following acute bronchiolitis in children. 2012 Cochrane Database Syst Rev pmid:23235681
Kao SS et al. 7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan. 2012 Gastroenterol Res Pract pmid:22888337
Boyanova L et al. Numerous risk factors for Helicobacter pylori antibiotic resistance revealed by extended anamnesis: a Bulgarian study. 2012 J. Med. Microbiol. pmid:21873378
Shah M et al. Transient Psychotic Episode Induced by Helicobacter pylori Triple Therapy Treatment. 2012 Case Rep Gastroenterol pmid:22855656
Heeb F et al. Organic micropollutants in rivers downstream of the megacity Beijing: sources and mass fluxes in a large-scale wastewater irrigation system. 2012 Environ. Sci. Technol. pmid:22845779
Wu W et al. Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication. 2012 Gastroenterol Res Pract pmid:22829809
Choi GE et al. Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance. 2012 Am. J. Respir. Crit. Care Med. pmid:22878281
Uno K et al. Rupture of renal mycotic aneurysm that developed during the treatment of streptococcal infective endocarditis and vertebral osteomyelitis. 2012 Intern. Med. pmid:22687800
Sano N et al. Comprehensive Analysis of Bacterial Flora in Postoperative Maxillary Cyst Fluid by 16S rRNA Gene and Culture Methods. 2012 ISRN Dent pmid:22685668
Lambiase A et al. In vitro resistance to macrolides and clindamycin by Group B Streptococcus isolated from pregnant and nonpregnant women. 2012 Infect Dis Obstet Gynecol pmid:22675244
Tatar EÇ et al. Prevalence of biofilms and their response to medical treatment in chronic rhinosinusitis without polyps. 2012 Otolaryngol Head Neck Surg pmid:22241786
Chang WJ et al. Successful salvage treatment of steroid-refractory bronchiolar COP with low-dose macrolides. 2012 Pathol. Int. pmid:22243785
Lismond A et al. Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium. 2012 Int. J. Antimicrob. Agents pmid:22245497
Agarwal E et al. Efficacy of local drug delivery of 0.5% clarithromycin gel as an adjunct to non-surgical periodontal therapy in the treatment of current smokers with chronic periodontitis: a randomized controlled clinical trial. 2012 J. Periodontol. pmid:22248223
Szałek E et al. Sunitinib in combination with clarithromycin or azithromycin - is there a risk of interaction or not? 2012 Pharmacol Rep pmid:23406766
Takeshima F et al. Successful management of cap polyposis with eradication of Helicobacter pylori relapsing 15 years after remission on steroid therapy. 2012 Intern. Med. pmid:22333383
Lawal TO et al. Combination studies of Eucalyptus torelliana F. Muell. leaf extracts and clarithromycin on Helicobacter pylori. 2012 Phytother Res pmid:22318891
Slater CM and Ford AC Treatment of Helicobacter pylori in Latin America. 2012 Lancet pmid:22305216
Choi GE et al. Activities of moxifloxacin in combination with macrolides against clinical isolates of Mycobacterium abscessus and Mycobacterium massiliense. 2012 Antimicrob. Agents Chemother. pmid:22564831
Lu ZM et al. Nucleosomes correlate with in vivo progression pattern of de novo methylation of p16 CpG islands in human gastric carcinogenesis. 2012 PLoS ONE pmid:22558275
Raithatha AH and Bryden DC Use of intravenous immunoglobulin therapy in the treatment of septic shock, in particular severe invasive group A streptococcal disease. 2012 Indian J Crit Care Med pmid:22557832
Ivetić Tkalčević V et al. Topical azithromycin and clarithromycin inhibit acute and chronic skin inflammation in sensitized mice, with apparent selectivity for Th2-mediated processes in delayed-type hypersensitivity. 2012 Inflammation pmid:21336676
Yang YH et al. Anti-Helicobacter pylori effects of IgY from egg york of immunized hens. 2012 Lab Anim Res pmid:22474475
Grosso F et al. A comprehensive safety analysis confirms rhabdomyolysis as an uncommon adverse reaction in patients treated with trabectedin. 2012 Cancer Chemother. Pharmacol. pmid:22484722
Federico A et al. Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection. 2012 Gastroenterology pmid:22484118
Monno R et al. Helicobacter pylori clarithromycin resistance detected by Etest and TaqMan real-time polymerase chain reaction: a comparative study. 2012 APMIS pmid:22882260
Pandya GJ et al. Unilateral lobar pulmonary edema. 2012 J Assoc Physicians India pmid:23547417
Ablanedo-Terrazas Y et al. Palatal Actinomycosis and Kaposi Sarcoma in an HIV-Infected Subject with Disseminated Mycobacterium avium-intracellulare Infection. 2012 Case Rep Med pmid:22481952
Fakheri H et al. A comparison between sequential therapy and a modified bismuth-based quadruple therapy for Helicobacter pylori eradication in Iran: a randomized clinical trial. 2012 Helicobacter pmid:22221615
Georgopoulos S et al. Evaluation of a four-drug, three-antibiotic, nonbismuth-containing "concomitant" therapy as first-line Helicobacter pylori eradication regimen in Greece. 2012 Helicobacter pmid:22221616
Humphrey B et al. Fitness of Escherichia coli strains carrying expressed and partially silent IncN and IncP1 plasmids. 2012 BMC Microbiol. pmid:22475035
Komatsu S et al. Clarithromycin enhances bortezomib-induced cytotoxicity via endoplasmic reticulum stress-mediated CHOP (GADD153) induction and autophagy in breast cancer cells. 2012 Int. J. Oncol. pmid:22200786
Matsuzaki J et al. Efficacy of sitafloxacin-based rescue therapy for Helicobacter pylori after failures of first- and second-line therapies. 2012 Antimicrob. Agents Chemother. pmid:22203601
Kobashi Y et al. Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period. 2012 J. Infect. Chemother. pmid:22205543
Lin Z and Will Y Evaluation of drugs with specific organ toxicities in organ-specific cell lines. 2012 Toxicol. Sci. pmid:22166485
Yeboah J and Sharma OP Co-existence of Crohn's disease, sarcoidosis and malignant lymphomas. 2012 JRSM Short Rep pmid:22393471
Martins TG et al. Local and regional re-establishment of cellular immunity during curative antibiotherapy of murine Mycobacterium ulcerans infection. 2012 PLoS ONE pmid:22393444
Legendre DP et al. Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions. 2012 Pharmacotherapy pmid:22392826
Li Y et al. A data-driven predictive approach for drug delivery using machine learning techniques. 2012 PLoS ONE pmid:22384063
Hong SJ The Role of Mycoplasma pneumoniae Infection in Asthma. 2012 Allergy Asthma Immunol Res pmid:22379599
Cavusoglu C et al. Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensititre RAPMYCO panel. 2012 New Microbiol. pmid:22378556
Sezikli M et al. Efficacy of the Combination of Tetracycline, Amoxicillin, and Lansoprazole in the Eradication of Helicobacter pylori in Treatment-Naïve Patients and in Patients Who Are Not Responsive to Clarithromycin-Based Regimens: A Pilot Study. 2012 Gut Liver pmid:22375169
Molina-Infante J et al. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains. 2012 Helicobacter pmid:22759326
Kongchayanun C et al. Pilot studies to identify the optimum duration of concomitant Helicobacter pylori eradication therapy in Thailand. 2012 Helicobacter pmid:22759328
Nguyen TV et al. Eradication of Helicobacter pylori in children in Vietnam in relation to antibiotic resistance. 2012 Helicobacter pmid:22759333
Nizič T et al. Solitary erythema migrans in children: comparison of treatment with clarithromycin and amoxicillin. 2012 Wien. Klin. Wochenschr. pmid:22760494
Yokota S et al. Clarithromycin suppresses human respiratory syncytial virus infection-induced Streptococcus pneumoniae adhesion and cytokine production in a pulmonary epithelial cell line. 2012 Mediators Inflamm. pmid:22761540
Brown-Elliott BA et al. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. 2012 Clin. Microbiol. Rev. pmid:22763637
Lopes R et al. [Antibiomania: a case of a manic episode induced by clarithromycin]. 2011 Sep-Oct Acta Med Port pmid:22525636
Yasar KK et al. Successfully treated Mycobacterium abscessus mastitis: a rare cause of breast masses. 2011 Oct-Dec Indian J Med Microbiol pmid:22120809
Eisig JN et al. Helicobacter pylori antibiotic resistance in Brazil: clarithromycin is still a good option. 2011 Oct-Dec Arq Gastroenterol pmid:22147131
Abadi AT et al. High frequency of A2143G mutation in clarithromycin-resistant Helicobacter pylori isolates recovered from dyspeptic patients in Iran. 2011 Nov-Dec Saudi J Gastroenterol pmid:22064338
Bilgili SG et al. Phototoxic dermatitis due to Chenopodium album in a child. 2011 Nov-Dec Pediatr Dermatol pmid:21854411
Lee CY et al. Digoxin toxicity precipitated by clarithromycin use: case presentation and concise review of the literature. 2011 Nov-Dec Can J Cardiol pmid:21907534
Zeng M et al. Comparison of efficacy of mometasone furoate versus clarithromycin in the treatment of chronic rhinosinusitis without nasal polyps in Chinese adults. 2011 Nov-Dec Am J Rhinol Allergy pmid:22185725
Mello CF and Negra MD Impact of macrolide therapy on mortality of HIV-infected patients with community-acquired pneumonia in a tertiary teaching hospital. 2011 May-Jun Braz J Infect Dis pmid:21670928
Schmidt D [The choice of treatment in HP associated ulcer: metronidazole or amoxicillin--nothing else!]. 2011 May 4-10 Lakartidningen pmid:21809531
Steyaert S et al. Soft tissue infections with atypical mycobacteria in two patients with inflammatory rheumatic diseases using TNF-inhibitors and/or leflunomide. 2011 Mar-Apr Acta Clin Belg pmid:21630616
Söderberg KC and Böttiger Y [Difficult choice between clarithromycin and metronidazole in polyneuropathy]. 2011 Mar 9-15 Lakartidningen pmid:21744557
Chung JW et al. The trends of one-week first-line and second-line eradication therapy for Helicobacter pylori infection in Korea. 2011 Jan-Feb Hepatogastroenterology pmid:21510323
Galmés-Truyols A et al. An outbreak of cutaneous infection due to Mycobacterium abscessus associated to mesotherapy. 2011 Aug-Sep Enferm. Infecc. Microbiol. Clin. pmid:21684045
Chen XZ et al. Synthesis and antibacterial activity of novel ketolides with 11,12-sulfur contained aryl alkyl side chains. 2011 Eur J Med Chem pmid:21130543
Ohe M and Hashino S A case of follicular B-cell lymphoma treated using clarithromycin. 2011 Korean J Hematol pmid:22065978
Mitchell CB et al. Infection with Mycobacterium immunogenum following a tattoo. 2011 J. Am. Acad. Dermatol. pmid:21496684
Gitti Z et al. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece. 2011 Future Microbiol pmid:21958147
Mencacci A et al. Legionella pneumophila serogroup 3 pneumonia in a patient with low-grade 4 non-Hodgkin lymphoma: a case report. 2011 J Med Case Rep pmid:21849075
Bohnert JA et al. Efflux inhibition by selective serotonin reuptake inhibitors in Escherichia coli. 2011 J. Antimicrob. Chemother. pmid:21700628
Hajiioannou JK et al. Clarithromycin induced reversible sensorineural hearing loss. 2011 B-ENT pmid:21838098
Rathi SK Acne vulgaris treatment : the current scenario. 2011 Indian J Dermatol pmid:21572783
Chin BS et al. The characteristics of metallo-β-lactamase-producing gram-negative bacilli isolated from sputum and urine: a single center experience in Korea. 2011 Yonsei Med. J. pmid:21319358